Assessment of ocrelizumab impact on neurofilament levels in multiple sclerosis patients
, , , and
Jul 31, 2024
About this article
Published Online: Jul 31, 2024
Page range: 245 - 254
Received: Apr 11, 2024
Accepted: Apr 23, 2024
DOI: https://doi.org/10.2478/rrlm-2024-0019
Keywords
© 2024 Smaranda Maier et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Maier, Smaranda
Department of Neurology, Faculty of Medicine, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu MuresRomania
Neurology 1 Clinic, Mures County Emergency Clinical HospitalTargu Mures, Romania
Huțanu, Adina
Department of Laboratory Medicine, Faculty of Medicine, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu MuresRomania
Central Laboratory, Mures County Emergency Clinical HospitalTargu Mures, Romania
Center for Advanced Medical and Pharmaceutical Research, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu MuresRomania
Bărcuțean, Laura
Department of Neurology, Faculty of Medicine, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu MuresRomania
Neurology 1 Clinic, Mures County Emergency Clinical HospitalTargu Mures, Romania
Sărmășan, Emanuela
Neurology 1 Clinic, Mures County Emergency Clinical HospitalTargu Mures, Romania
Bălașa, Rodica
Department of Neurology, Faculty of Medicine, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu MuresRomania
Neurology 1 Clinic, Mures County Emergency Clinical HospitalTargu Mures, Romania